Login / Signup

Reporting bias in clinical trials: Progress toward transparency and next steps.

Mayookha Mitra-MajumdarAaron S Kesselheim
Published in: PLoS medicine (2022)
Mayookha Mitra-Majumdar and Aaron Kesselheim reflect on steps taken to combat reporting bias in clinical trials over the last two decades.
Keyphrases
  • clinical trial
  • adverse drug
  • phase ii
  • open label
  • double blind
  • phase iii
  • study protocol
  • emergency department
  • electronic health record
  • drug induced